TUESDAY, Oct. 27 (HealthDay News) -- Arzerra (ofatumumab) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia (CLL), a cancer of the blood and bone marrow.
The drug, produced by London-based GlaxoSmithKline, is approved when other types of chemotherapy no longer control the disease, the FDA said in a news release.
CLL, a slowly progressing form of leukemia, mostly affects people aged 50 and older. Some 16,000 people annually are diagnosed with the disease, and about 4,400 die, the agency said.
Arzerra binds to white blood cells known as B cells, making it easier for the body's immune system to fight cancerous B cells. The drug was approved under an accelerated process granted to drugs that satisfy unmet medical needs, the FDA said. Ongoing studies will establish whether combining Arzerra with standard forms of chemotherapy delays progression of CLL.
Common side effects recorded during clinical testing of Arzerra included an increased risk of progressive multifocal leukoencephalopathy (PML), an often-fatal brain infection. Also, people with a history of hepatitis should be carefully monitored while taking the drug.
Other side effects may include a decrease in blood cell counts, pneumonia, fever, cough, diarrhea, fatigue and shortness of breath, the FDA said.
More information
The FDA has more about this drug's approval history.
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Today's Top News Stories |
• | Stifled Anger at Work Doubles Men's Risk for Heart Attack - Nov 23, 2009, 19:00
More open on-the-job interaction might ease the problem, researchers say. |
• | Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says - Nov 23, 2009, 16:00
Dr. Bernadine Healy, first woman to head the agency, said lives could be at risk. |
• | Vioxx Problems Known Years Before Recall - Nov 23, 2009, 16:00
Study points up weaknesses of drug approval process in United States, researcher says. |
• | Clinical Trials Update: Nov. 23, 2009 - Nov 23, 2009, 10:54
- Psoriasis
- High Blood Pressure
- Bipolar Disorder
|
• | One in Four Teen Girls Have STDs - Nov 23, 2009, 12:00
Almost 20 percent get infected within one year of starting to have sex, CDC report says. |
